The MyPGt™ genetic test is used to inform and enhance decision-making when prescribing medications and treatments for a broad spectrum of psychiatric conditions.
Genetic results provide an important piece of evidence for the diversity observed in medication response. Genetic results offer valuable information about the likelihood that a patient will respond to a medication therapy and/or experience adverse events or drug interactions.
Treatment decisions informed by these genetic results can offer a personalized and more precise treatment plan to patients who are suffering from continued symptoms or side effects.
The genes analyzed in the MyPGt™ test are associated with a wide range of medications and can help to inform treatment plans for depression, anxiety, obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), bipolar disorder, post-traumatic stress disorder (PTSD), autism, schizophrenia, chronic pain and substance abuse.